Risk factors of elevated blood ammonia level in epilepsy patients treated with lamotrigine

Medicine (Baltimore). 2022 Jul 1;101(26):e29780. doi: 10.1097/MD.0000000000029780.

Abstract

AbstractThe aim of this study was to explore the effect of lamotrigine (LTG) on blood ammonia level in patients with epilepsy and identify risk factors affecting blood ammonia level. This study included 91 epilepsy patients who were treated with LTG at Department of Neurology, Zhongshan Hospital, Xiamen University from January 2011 to April 2016, and were followed up for 3 years. Blood samples were taken during the interictal state and analyzed for blood LTG and ammonia levels. Total of 46.1% of the samples exceeded the median blood ammonia level, and 2.1% of patients had hyperammonemia. Blood ammonia level was positively correlated with LTG blood concentration. LTG combined with valproic acid therapy, seizure within 1 year, and elevated neutrophils affected blood ammonia level. Blood ammonia level was significantly correlated with plasma concentration of LTG. LTG combined with valproic acid therapy, seizure within 1 year, and elevated neutrophils may be risk factors for elevated blood ammonia level in epilepsy patients treated with LTG.

MeSH terms

  • Ammonia
  • Anticonvulsants / adverse effects
  • Epilepsy* / chemically induced
  • Epilepsy* / drug therapy
  • Humans
  • Hyperammonemia* / chemically induced
  • Lamotrigine / therapeutic use
  • Risk Factors
  • Seizures / drug therapy
  • Triazines / adverse effects
  • Triazines / therapeutic use
  • Valproic Acid

Substances

  • Anticonvulsants
  • Triazines
  • Valproic Acid
  • Ammonia
  • Lamotrigine